An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)
Clinical trial NCT04563338 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04563338
- Sponsor
- University Health Network, Toronto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-04
- Primary completion
- 2024-06-25
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.